Reference Tool
Compare Compounds
Place up to three reference compounds side by side to compare their molecular profile, pharmacokinetics, and handling.
| Attribute | ss-31-elamipretide | nad | retatrutide |
|---|---|---|---|
| Field of Medicine | Mitochondrial Medicine · Cardiology Research | Mitochondrial Medicine · Geroscience Research | Endocrinology · Metabolic Research |
| Category | mitochondrial | mitochondrial | incretin |
| Formula | C32H49N9O5 | C21H27N7O14P2 | — |
| Molecular Weight | 639.79 Da | 663.43 Da | ~4731 Da |
| Sequence | D-Arg-Dmt-Lys-Phe-NH2 (Szeto-Schiller tetrapeptide) | — | 39-amino-acid triple agonist (GLP-1 / GIP / glucagon) |
| CAS Number | — | 53-84-9 | — |
| Half-Life | ~2–3 hours | — | ~6 days |
| Route (research) | — | Intravenous, subcutaneous, or intramuscular in research | Subcutaneous in research models |
| Onset / Steady-state | — | — | — |
| Lyophilized Storage | −20°C long term; 2–8°C short term (weeks). Protect from light. | −20°C long term; 2–8°C short term (weeks). Protect from light. | −20°C long term; 2–8°C short term (weeks). Protect from light. |
| Reconstituted Storage | 2–8°C, generally up to 14–28 days depending on compound. | 2–8°C, generally up to 14–28 days depending on compound. | 2–8°C, generally up to 14–28 days depending on compound. |